ZIPSCRIPT
Live / Registered — Registered (as of 22 Apr 2025)
What this means for you
Registered since 22 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98610161
- Registration number
- 7766517
- Mark type
- Stylized text
- Filed
- 20 Jun 2024
- Published for opposition
- 04 Mar 2025
- Registered
- 22 Apr 2025
- Attorney of record
- Randolph E. Digges, III
Goods and services
- Class 001 — Chemicals: Chemical, biochemical and biotechnological diagnostic preparations for scientific purposes, namely, buffer solutions for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning; chemical test kits for laboratory or research use featuring chemicals for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning
- Class 005 — Pharmaceuticals: Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits comprised of preparations for medical and veterinary diagnostic purposes, namely, preparations for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes
Owner
- QIAGEN Beverly, LLC, Beverly, MA, US
- QIAGEN Beverly, LLC, Beverly, MA, US
- QIAGEN Beverly, LLC, Beverly, MA, US
Prosecution history
- 22 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 04 Mar 2025 — PUBLISHED FOR OPPOSITION
- 04 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Feb 2025 — EXAMINER'S AMENDMENT ENTERED
- 11 Feb 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 11 Feb 2025 — EXAMINERS AMENDMENT E-MAILED
- 11 Feb 2025 — EXAMINERS AMENDMENT -WRITTEN
- 23 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Jan 2025 — NON-FINAL ACTION E-MAILED
- 23 Jan 2025 — NON-FINAL ACTION WRITTEN
- 14 Jan 2025 — ASSIGNED TO EXAMINER
- 13 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED